Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Bielli & Klauder
- Tarter Krinsky
- Teitelbaum Law Group
- Hagens Berman
- Simmons Hanly
- Debevoise & Plimpton
- Godfrey & Kahn
- Motley Rice
- Himes Petrarca
- Wachtell Lipton
- Hurwitz Fine
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- FBT Gibbons
- Pashman Stein
- Goodwin Procter
- Doster Ullom
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- ArentFox Schiff
- Dentons
- Faegre Drinker
- Duane Morris
- Foley & Lardner
- Jones Day
- Davis Polk
- Porter Hedges
- Willkie Farr
- Bentley & Bruning
- ASK LLP
- Hogan Lovells
- Joseph Hage
- Marino Tortorella
- White & Case
- UB Greensfelder
- HSF Kramer
- Seyfarth Shaw
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Blank Rome
- Kirkland & Ellis
- Cronin Fried
- Loeb & Loeb
- Phillips Lytle
- Arnold & Porter
- Slevin & Hart
- Troutman
- Doshi Legal Group
- Plevin & Turner
- Schenck Price
- Lerner Arnold
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Saul Ewing
- Taft Stettinius
- Burke Warren
- Wilk Auslander
- Stutzman Bromberg
- Shook Hardy
- Sherrard Roe
- Consovoy McCarthy
- Cleary Gottlieb
- Napoli Shkolnik
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- Potter Anderson
- Stevens & Lee
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Pillsbury Winthrop
- Robins Kaplan
- WilmerHale
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Levenfeld Pearlstein
- Rothstein Mandell
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Johnson & Johnson
- FTI Consulting Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- KVK Tech Inc.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- The Cigna Group
- Viatris Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- AlixPartners LLP
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- State of Nevada
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- U.S. District Court for the District of Columbia
- Borough of Paramus, New Jersey
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
September 24, 2021
California AG Announces Appeal Of Purdue Ch. 11 Plan
California Attorney General Rob Bonta on Friday became the latest attorney general to announce an appeal of the approval of Purdue Pharma's Chapter 11 plan, saying the OxyContin maker's former owners in the Sackler family must be held accountable for their part in the opioid crisis.
-
September 22, 2021
US Trustee Challenges Constitutionality Of Purdue Releases
The nondebtor, third-party releases included in Purdue Pharma's Chapter 11 plan are unconstitutional, the U.S. Trustee's Office has argued, asking a New York bankruptcy judge to wait until a higher court rules on the federal watchdog's challenge to the releases.
-
September 16, 2021
US Trustee To Appeal Sackler Releases In Purdue Ch. 11
The U.S. Trustee's Office has told a New York bankruptcy judge it will appeal his order approving Purdue Pharma's Chapter 11 plan, saying the plan's liability releases for Purdue's Sackler family now-former owners go beyond the law and undermine confidence in the system.
-
September 13, 2021
Purdue Pharma Gets OK For $7.1M In Exec Incentives
A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7.1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture.
-
September 01, 2021
Purdue Pharma Ch. 11 Plan Gets OK With Sackler Releases
A New York bankruptcy judge on Wednesday approved OxyContin maker Purdue Pharma's Chapter 11 plan, including contentious opioid liability releases for the company's now-former Sackler family owners.
-
August 27, 2021
Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases
Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.
-
August 25, 2021
Purdue Ch. 11 Judge Says Sackler Releases Should Be Tighter
A New York bankruptcy judge on Wednesday urged Purdue Pharma to narrow the nonopioid liability releases it is granting members of its owning Sackler family as he prepared to make his judgment on Purdue's Chapter 11 plan on Friday.
-
August 23, 2021
No More Speeches, Settle This Ch. 11, Purdue Judge Urges
Telling the parties Monday that "the time has passed at this point to speechify," the New York bankruptcy judge overseeing Purdue Pharma's bankruptcy urged the objecting states and the owning members of the Sackler family to settle their differences before the confirmation hearing resumes Wednesday.
-
August 19, 2021
Judge Urges Attention To Individual Stories In Purdue Ch. 11
The sixth day of evidence in Purdue Pharma's Chapter 11 plan confirmation hearing ended Thursday with the judge walking off camera after a declaration that the damage individuals have suffered in the opioid crisis should not be lost in the complexities of the bankruptcy case.
-
August 18, 2021
Ex-Purdue Chair Denies Blame For Opioid Crisis
A former president and board chairman of Purdue Pharma on Wednesday denied that the company or its owners in the Sackler family bore responsibility for the United States' opioid crisis as the confirmation hearing for Purdue's Chapter 11 plan entered its fifth day.